PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System

被引：11
|
作者：
Shu, Linjing [1 ,2 ]
Huang, Renhuan [1 ]
Wu, Songtao [1 ]
Chen, Zhaozhao [1 ]
Sun, Ke [1 ]
Jiang, Yan [1 ]
Cai, Xiaoxiao [1 ]
机构：
[1] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, 14,3rd Sec,Ren Min Nan Rd, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, West China Hosp Stomatol, Dept Oral Implantol Ctr, Chengdu 610041, Sichuan Provinc, Peoples R China
来源：
CURRENT STEM CELL RESEARCH & THERAPY | 2016年 / 11卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Antitumor; chemoprevention; digestive system; peroxisome proliferator-activated receptor gamma; thiazolidinediones (TZDs); tumor cells; ACTIVATED-RECEPTOR-GAMMA; INHIBITS CELL-GROWTH; PANCREATIC-CANCER CELLS; MOUSE COLON CARCINOGENESIS; CARCINOMA IN-VITRO; GASTRIC-CANCER; COLORECTAL-CANCER; LINOLEIC-ACID; PERITONEAL METASTASIS; INDUCED APOPTOSIS;
D O I：
10.2174/1574888X10666150630111618
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a versatile member of the ligand-activated nuclear hormone receptor superfamily of transcription factors, with expression in several different cell lines, especially in the digestive system. After being activated by its ligand, PPAR gamma can suppress the growth of oral, esophageal, gastric, colorectal, liver, biliary, and pancreatic tumor cells, suggesting that PPAR gamma ligand is a potential anticancer agent in PPAR gamma-expressing tumors. This review highlights key advances in understanding the effects of PPAR gamma ligands in the treatment of tumors in the digestive system.
引用
收藏
页码：274 / 281
页数：8
相关论文
共 50 条
  • [21] Copper (II)-Surfactant Complex and Its Nano Analog as Potential Antitumor Agents
    Badawi, Abdelftah M.
    Zakhary, Nadia I.
    Morsy, Salwa M. I.
    Sabry, Gilane M.
    Mohamed, Mohamed R.
    Mousa, Ahmed M.
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2009, 30 (09) : 1303 - 1309
  • [22] Copper (II)-surfactant complex and its nano analogue as potential antitumor agents
    Badawi, Abdelftah M.
    Zakhary, Nadia E.
    Morsy, Salwa M. I.
    Sabry, Gilane M.
    Mohamed, Mohamed R.
    Mousa, Ahmed M.
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 10, 2008, 10 : 158 - +
  • [23] AZIRIDINYLBENZOQUINONES AS POTENTIAL CNS ANTITUMOR AGENTS
    DRISCOLL, JS
    CHOU, F
    KHAN, AH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1976, 172 (SEP3): : 82 - 82
  • [24] ASYMMETRICAL BISINTERCALATORS AS POTENTIAL ANTITUMOR AGENTS
    LEON, P
    GARBAYJAUREGUIBERRY, C
    LAMBERT, B
    LEPECQ, JB
    ROQUES, BP
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (05) : 1021 - 1026
  • [25] Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents
    Sun, Yanyan
    Wei, Huaixin
    Zhang, Qiang
    Zhao, Xin
    CHEMISTRY & BIODIVERSITY, 2019, 16 (01)
  • [26] PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes
    Baranova, Ancha
    PPAR RESEARCH, 2008, 2008
  • [27] Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis
    Giaginis, Costas
    Giagini, Athina
    Theocharis, Stamatios
    PHARMACOLOGICAL RESEARCH, 2009, 60 (03) : 160 - 169
  • [28] Synthesis of Phthalimide Derivatives as Potential PPAR-γ Ligands
    Eom, So Hyeon
    Liu, Sen
    Su, Mingzhi
    Noh, Tae Hwan
    Hong, Jongki
    Kim, Nam Deuk
    Chung, Hae Young
    Yang, Min Hye
    Jung, Jee H.
    MARINE DRUGS, 2016, 14 (06)
  • [29] POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2.
    CHOU, F
    KHAN, AH
    DRISCOLL, JS
    JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) : 1302 - 1308
  • [30] Development of Heterocyclic PPAR Ligands for Potential Therapeutic Applications
    Virendra, Sharma Arvind
    Kumar, Ankur
    Chawla, Pooja A.
    Mamidi, Narsimha
    PHARMACEUTICS, 2022, 14 (10)
12345